Mane acquires Chemosensoryx Biosciences to advance its receptor-based research

By Amanda May | Published: 16-Jan-2026

Fragrance and flavour giant Mane Group has bought the Belgian biotech firm for an undisclosed sum to advance its expertise in how smells, tastes and sensations are perceived

Mane Group has acquired Belgian biotech company Chemosensoryx Biosciences to accelerate its “sensory innovation”.

The Grasse, France-based flavour and fragrance supplier said the deal will enable it to deepen its scientific understanding of how smells, tastes and sensations, such as freshness and spiciness, are perceived.

Chemosensoryx Biosciences is an expert in the molecular mechanism of chemosensory perception, mediated by olfactory, gustatory and trigeminal receptors.

The financial terms of the sale have not been disclosed.

Mane Group will use the biotech firm’s technology platform in receptor-based screening and predictive modelling to enhance its capabilities in several key areas.

This includes odour control, blooming technologies and taste modulation research to support the development of next-generation taste solutions.

Plus, olfactory receptor modulation to guide the design of flavours and fragrances that “trigger targeted emotional and physiological responses”; and trigeminal receptor modulation to support advanced research programmes. 

“With an experienced team of scientists with a strong expertise in molecular and cellular biology, ChemoSensoryx is a leading discovery company in the field of olfactory, taste and trigeminal receptors,” said Samantha Mane, CEO of Mane Group.

“We are delighted to welcome the ChemoSensoryx team to the Mane family.

“This acquisition will reinforce Mane’s capabilities to deliver global and ever-evolving expertise in flavours and fragrances solutions, creating lasting and successful products.”

Mane Group has 52 R&D centres and 31 production sites around the world, employing more than 8,000 people in 40 countries.

Related content:

You may also like